NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity
K. Ingram, S. C. Samson, R. Zewdu, R. G. Zitnay, E. L. Snyder, M. C. Mendoza
This study shows NKX2-1 suppresses lung cancer progression by inducing DUSP6, which reduces ERK activity, and demonstrates this effect in human samples, cell lines, and mouse models.
bioRxiv · Mar 4, 2021Cancer Biology